Product Program year 2025 Source: CMS Open Payments

Bulkamid

Device Bulkamid - Bulkamid 3mL - URO

PDI 10810005340493

Open in the dashboard

General payments

$4,456

70 payments

Research payments

$0

0 payments

Through program year 2025, $4,456 in general payments and $0 in research payments were reported against Bulkamid (Bulkamid 3mL - URO).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $4,456 70

Breakdown

Who paid General payments · program year 2025
  1. Boston Scientific Corporation $4,456 70 payments
Top recipients General payments · program year 2025
  1. Eduardo Muniz - Velez Obstetrics & Gynecology · San Juan, PR $175 4% · 2 payments
  2. Fidel Santos Santos Urogynecology and Reconstructive Pelvic Surgery · San Juan, PR $175 4% · 2 payments
  3. Erik Hokenstad Obstetrics & Gynecology · Rochester, MN $149 3% · 1 payment
  4. Robert Harris Gynecology · Flowood, MS $125 3% · 1 payment
  5. Steven Speights Urogynecology and Reconstructive Pelvic Surgery · Flowood, MS $125 3% · 1 payment

The top 5 of 66 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Urogynecology and Reconstructive Pelvic Surgery Obstetrics & Gynecology $1,497 35% · 18 practitioners
  2. Obstetrics & Gynecology $1,360 32% · 18 practitioners
  3. Urology $447 10% · 14 practitioners
  4. Gynecology Obstetrics & Gynecology $307 7% · 3 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $233 5% · 2 practitioners

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Puerto Rico $1,134 25% · 11 recipients
  2. Mississippi $625 14% · 5 recipients
  3. California $595 13% · 23 recipients
  4. Massachusetts $497 11% · 5 recipients
  5. Ohio $423 9% · 5 recipients

The top 5 of 15 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

70 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record